SLIT TR-03 (Transave)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSLIT TR-03 (Transave)
Drug Alias Namelung cancer gene therapy (Transave)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTransave Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransave Inc
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A